285 related articles for article (PubMed ID: 21625220)
1. Overexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growth.
Taniuchi K; Cerny RL; Tanouchi A; Kohno K; Kotani N; Honke K; Saibara T; Hollingsworth MA
Oncogene; 2011 Dec; 30(49):4843-54. PubMed ID: 21625220
[TBL] [Abstract][Full Text] [Related]
2. COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer.
Hofmann BT; Schlüter L; Lange P; Mercanoglu B; Ewald F; Fölster A; Picksak AS; Harder S; El Gammal AT; Grupp K; Güngör C; Drenckhan A; Schlüter H; Wagener C; Izbicki JR; Jücker M; Bockhorn M; Wolters-Eisfeld G
Mol Cancer; 2015 May; 14():109. PubMed ID: 26021314
[TBL] [Abstract][Full Text] [Related]
3. Loss of N-acetylgalactosaminyltransferase 3 in poorly differentiated pancreatic cancer: augmented aggressiveness and aberrant ErbB family glycosylation.
Chugh S; Meza J; Sheinin YM; Ponnusamy MP; Batra SK
Br J Cancer; 2016 Jun; 114(12):1376-86. PubMed ID: 27187683
[TBL] [Abstract][Full Text] [Related]
4. Expression of three UDP-N-acetyl-alpha-D-galactosamine:polypeptide GalNAc N-acetylgalactosaminyltransferases in adenocarcinoma cell lines.
Sutherlin ME; Nishimori I; Caffrey T; Bennett EP; Hassan H; Mandel U; Mack D; Iwamura T; Clausen H; Hollingsworth MA
Cancer Res; 1997 Nov; 57(21):4744-8. PubMed ID: 9354435
[TBL] [Abstract][Full Text] [Related]
5. Expression of uridine diphosphate N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyl transferase 3 in adenocarcinoma of the pancreas.
Yamamoto S; Nakamori S; Tsujie M; Takahashi Y; Nagano H; Dono K; Umeshita K; Sakon M; Tomita Y; Hoshida Y; Aozasa K; Kohno K; Monden M
Pathobiology; 2004; 71(1):12-8. PubMed ID: 14555840
[TBL] [Abstract][Full Text] [Related]
6. Loss of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3 and reduced O-glycosylation in colon carcinoma cells selected for hepatic metastasis.
Kato K; Takeuchi H; Kanoh A; Miyahara N; Nemoto-Sasaki Y; Morimoto-Tomita M; Matsubara A; Ohashi Y; Waki M; Usami K; Mandel U; Clausen H; Higashi N; Irimura T
Glycoconj J; 2010 Feb; 27(2):267-76. PubMed ID: 20077002
[TBL] [Abstract][Full Text] [Related]
7. The expression pattern of UDP-N-acetyl-alpha-d-galactosamine: polypeptide N-acetylgalactosaminyl transferase-3 in early gastric carcinoma.
Ishikawa M; Kitayama J; Nariko H; Kohno K; Nagawa H
J Surg Oncol; 2004 Apr; 86(1):28-33. PubMed ID: 15048677
[TBL] [Abstract][Full Text] [Related]
8. Expression of UDP-N-acetyl-alpha-D-galactosamine-polypeptide galNAc N-acetylgalactosaminyl transferase-3 in relation to differentiation and prognosis in patients with colorectal carcinoma.
Shibao K; Izumi H; Nakayama Y; Ohta R; Nagata N; Nomoto M; Matsuo K; Yamada Y; Kitazato K; Itoh H; Kohno K
Cancer; 2002 Apr; 94(7):1939-46. PubMed ID: 11932895
[TBL] [Abstract][Full Text] [Related]
9.
Lavrsen K; Dabelsteen S; Vakhrushev SY; Levann AMR; Haue AD; Dylander A; Mandel U; Hansen L; Frödin M; Bennett EP; Wandall HH
J Biol Chem; 2018 Jan; 293(4):1298-1314. PubMed ID: 29187600
[TBL] [Abstract][Full Text] [Related]
10. Cloning, expression and properties of porcine trachea UDP-galnac: polypeptide N-acetylgalactosaminyl transferase.
Sangadala S; Swain JB; McNear A; Mendicino J
Mol Cell Biochem; 2004 Nov; 266(1-2):117-26. PubMed ID: 15646032
[TBL] [Abstract][Full Text] [Related]
11. Substrate specificities of three members of the human UDP-N-acetyl-alpha-D-galactosamine:Polypeptide N-acetylgalactosaminyltransferase family, GalNAc-T1, -T2, and -T3.
Wandall HH; Hassan H; Mirgorodskaya E; Kristensen AK; Roepstorff P; Bennett EP; Nielsen PA; Hollingsworth MA; Burchell J; Taylor-Papadimitriou J; Clausen H
J Biol Chem; 1997 Sep; 272(38):23503-14. PubMed ID: 9295285
[TBL] [Abstract][Full Text] [Related]
12. Cloning of a human UDP-N-acetyl-alpha-D-Galactosamine:polypeptide N-acetylgalactosaminyltransferase that complements other GalNAc-transferases in complete O-glycosylation of the MUC1 tandem repeat.
Bennett EP; Hassan H; Mandel U; Mirgorodskaya E; Roepstorff P; Burchell J; Taylor-Papadimitriou J; Hollingsworth MA; Merkx G; van Kessel AG; Eiberg H; Steffensen R; Clausen H
J Biol Chem; 1998 Nov; 273(46):30472-81. PubMed ID: 9804815
[TBL] [Abstract][Full Text] [Related]
13. Localization of three human polypeptide GalNAc-transferases in HeLa cells suggests initiation of O-linked glycosylation throughout the Golgi apparatus.
Röttger S; White J; Wandall HH; Olivo JC; Stark A; Bennett EP; Whitehouse C; Berger EG; Clausen H; Nilsson T
J Cell Sci; 1998 Jan; 111 ( Pt 1)():45-60. PubMed ID: 9394011
[TBL] [Abstract][Full Text] [Related]
14. Isoform-specific O-glycosylation by murine UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-T3, in vivo.
Nehrke K; Hagen FK; Tabak LA
Glycobiology; 1998 Apr; 8(4):367-71. PubMed ID: 9499384
[TBL] [Abstract][Full Text] [Related]
15. Initiation of O-glycan synthesis in IgA1 hinge region is determined by a single enzyme, UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2.
Iwasaki H; Zhang Y; Tachibana K; Gotoh M; Kikuchi N; Kwon YD; Togayachi A; Kudo T; Kubota T; Narimatsu H
J Biol Chem; 2003 Feb; 278(8):5613-21. PubMed ID: 12438318
[TBL] [Abstract][Full Text] [Related]
16. The lectin domain of the polypeptide GalNAc transferase family of glycosyltransferases (ppGalNAc Ts) acts as a switch directing glycopeptide substrate glycosylation in an N- or C-terminal direction, further controlling mucin type O-glycosylation.
Gerken TA; Revoredo L; Thome JJ; Tabak LA; Vester-Christensen MB; Clausen H; Gahlay GK; Jarvis DL; Johnson RW; Moniz HA; Moremen K
J Biol Chem; 2013 Jul; 288(27):19900-14. PubMed ID: 23689369
[TBL] [Abstract][Full Text] [Related]
17. Low expression of polypeptide GalNAc N-acetylgalactosaminyl transferase-3 in lung adenocarcinoma: impact on poor prognosis and early recurrence.
Gu C; Oyama T; Osaki T; Li J; Takenoyama M; Izumi H; Sugio K; Kohno K; Yasumoto K
Br J Cancer; 2004 Jan; 90(2):436-42. PubMed ID: 14735190
[TBL] [Abstract][Full Text] [Related]
18. UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase- 6 (pp-GalNAc-T6): Role in Cancer and Prospects as a Drug Target.
Banford S; Timson DJ
Curr Cancer Drug Targets; 2017; 17(1):53-61. PubMed ID: 27659430
[TBL] [Abstract][Full Text] [Related]
19. Immunolocalisation of members of the polypeptide N-acetylgalactosaminyl transferase (ppGalNAc-T) family is consistent with biologically relevant altered cell surface glycosylation in breast cancer.
Brooks SA; Carter TM; Bennett EP; Clausen H; Mandel U
Acta Histochem; 2007; 109(4):273-84. PubMed ID: 17448526
[TBL] [Abstract][Full Text] [Related]
20. Engineering of N. benthamiana L. plants for production of N-acetylgalactosamine-glycosylated proteins--towards development of a plant-based platform for production of protein therapeutics with mucin type O-glycosylation.
Daskalova SM; Radder JE; Cichacz ZA; Olsen SH; Tsaprailis G; Mason H; Lopez LC
BMC Biotechnol; 2010 Aug; 10():62. PubMed ID: 20735851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
